An ongoing dialogue on HIV/AIDS, infectious diseases,
February 14th, 2023
Interferon Lambda for COVID-19 — Looking Good, but Still Not Available
Way back in the spring of 2022, I was asked to give an update on outpatient treatment of COVID to a group of general internists. The talk featured this slide on the TOGETHER trial of peginterferon lambda: These data came from a press release from the company developing the drug. It’s dated March 17, 2022. I added […]